Cite
Patients Selection for Immunotherapy in Solid Tumors: Overcome the Naïve Vision of a Single Biomarker.
MLA
Signorelli, Diego, et al. “Patients Selection for Immunotherapy in Solid Tumors: Overcome the Naïve Vision of a Single Biomarker.” BioMed Research International, Apr. 2019, pp. 1–15. EBSCOhost, https://doi.org/10.1155/2019/9056417.
APA
Signorelli, D., Giannatempo, P., Grazia, G., Aiello, M. M., Bertolini, F., Mirabile, A., Buti, S., Vasile, E., Scotti, V., Pisapia, P., Cona, M. S., Rolfo, C., Malapelle, U., & Group, I.-O. Y. O. U. N. G. (2019). Patients Selection for Immunotherapy in Solid Tumors: Overcome the Naïve Vision of a Single Biomarker. BioMed Research International, 1–15. https://doi.org/10.1155/2019/9056417
Chicago
Signorelli, Diego, Patrizia Giannatempo, Giulia Grazia, Marco Maria Aiello, Federica Bertolini, Aurora Mirabile, Sebastiano Buti, et al. 2019. “Patients Selection for Immunotherapy in Solid Tumors: Overcome the Naïve Vision of a Single Biomarker.” BioMed Research International, April, 1–15. doi:10.1155/2019/9056417.